|
5. Capital stock
|
9 Months Ended |
|---|---|
|
Sep. 30, 2012
|
|
| Stockholders' Equity Note [Abstract] | |
| Note 5. Capital stock |
5. Capital stock
During the nine months ended September 30, 2012, the Company issued 14,155,006 shares of common stock in exchange for conversion of $3,741,784 of Convertible Notes.
During the nine months ended September 30, 2012, the Company issued 6,224,844 shares of common stock upon exercise of warrants at an average price of $0.28 per share and valued at $1,762,693.
During the nine months ended September 30, 2012, the Company issued 2,525,000 shares of common stock for consulting services at an average price of $0.47 per share and valued at $1,228,250. The shares issued were valued at the trading price at the date of the agreement.
During the nine months ended September 30, 2012, the Company issued 58,334 shares of common stock upon exercise of options at $0.27 per share and valued at $15,750.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|